Free Trial

Harmony Biosciences (HRMY) SEC Filings & 10K Form

$33.75
+0.43 (+1.29%)
(As of 07/12/2024 ET)

Recent Harmony Biosciences SEC Filings

DateFilerForm TypeView
05/31/2024
7:57 AM
Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
7:58 AM
Harmony Biosciences (Issuer)
Sender Gary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
7:52 AM
Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
7:53 AM
Harmony Biosciences (Issuer)
Szyper Linda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
7:54 AM
Harmony Biosciences (Issuer)
Nielsen Jack (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
7:54 AM
Graf R. Mark (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
7:55 AM
Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:01 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
7:05 AM
Budur Kumar (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
7:00 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2024
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
8:44 AM
Harmony Biosciences (Filer)
Form ARS
04/11/2024
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
7:17 AM
Harmony Biosciences (Filer)
Form DEF 14A
04/11/2024
7:18 AM
Harmony Biosciences (Filer)
Form DEFA14A
03/18/2024
6:24 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:24 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
4:17 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:21 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
4:16 PM
Harmony Biosciences (Filer)
Form 10-K/A
02/22/2024
7:00 AM
Harmony Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
6:06 PM
Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
Form SC 13G/A
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
Form SC 13G/A
01/08/2024
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
7:59 AM
Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2023
8:03 AM
Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2023
7:00 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2023
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2023
7:31 AM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T/A
10/11/2023
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
1:34 PM
BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
Form SC 13G/A
10/05/2023
3:15 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
3:15 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
7:12 AM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T/A
09/25/2023
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:59 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T/A
There’s something very “off” about this situation (Ad)

The stock is now trading for just $10 a share. Why is this company being ignored by Wall Street, and what kind of gains could shareholders soon be looking at?

In my new video, I outline everything I believe is going to happen with this company. 
09/14/2023
3:42 PM
Harmony Biosciences (Filer)
Form 8-K/A
08/28/2023
7:23 AM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T
08/24/2023
4:23 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC 13D
08/14/2023
4:26 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-C
08/14/2023
4:27 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
4:29 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-C
08/01/2023
7:01 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2023
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:HRMY) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners